2018-09-05T10:08:05-05:00 2017-12-31 Grant Thornton LLP 100 E Wisconsin Ave Milwaukee WI 53202 990 2017-01-01 381550001 Michigan Blood % JODI YENCHAR MICH 6167742300 PO Box 1704 Grand Rapids MI 495011704 JAMES WILSON President 4142898200 2018-09-04 true Michelle L Weber P00556798 4142898200 2018-08-24 2017 2022-09-23 18:48:47Z JAMES WILSON PO Box 1704 Grand Rapids MI 495011704 82112650 false X www.miblood.org X 1955 MI HELPING PEOPLE MAKE A LIFESAVING DIFFERENCE THROUGH BLOOD PRODUCTS AND SERVICE EXCELLENCE 15 14 522 381 0 0 490987 402706 55986833 55469278 331865 710835 -7710 -2882 56801975 56579937 0 0 0 0 22350932 22264185 0 0 0 34715057 32875360 57065989 55139545 -264014 1440392 35404153 37358913 6672254 6534165 28731899 30824748 X THE PURPOSE OF MICHIGAN BLOOD IS TO PROVIDE A SAFE AND ADEQUATE BLOOD SUPPLY AND BLOOD-RELATED SERVICES FOR THE COMMUNITIES SERVED BY HOSPITAL PARTNERS THROUGHOUT THE STATE. MICHIGAN BLOOD IS THE SOLE PROVIDER OF BLOOD FOR 62 HOSPITAL FACILITIES. THESE HOSPITALS INCLUDE MAJOR MEDICAL CENTERS (SECONDARY- AND TERTIARY-CARE TEACHING FACILITIES) SERVING POPULATIONS TOTALING MORE THAN 2.5 MILLION PEOPLE. MICHIGAN BLOOD SUPPORTS ANOTHER 10 HOSPITALS THROUGH SUPPLEMENTAL CONTRACTS. THROUGH DONOR CENTERS AND BLOOD DRIVES IN NORTHWEST, EAST-CENTRAL, WEST, SOUTHWEST AND SOUTHEAST MICHIGAN, MICHIGAN BLOOD RECRUITS AND COLLECTS BLOOD FROM VOLUNTEER DONORS TO ACHIEVE ITS LIFESAVING MISSION. ANNUALLY, MICHIGAN BLOOD COLLECTS APPROXIMATELY 135,000 PRODUCTIVE UNITS AND DISTRIBUTES 289,000 BLOOD COMPONENTS. false false 47149196 0 55469278 FOR OVER 62 YEARS, MICHIGAN BLOOD HAS PROUDLY SERVED MICHIGAN HOSPITALS AS AN INDEPENDENT, COMMUNITY-BASED, NONPROFIT BLOOD CENTER. IN ADDITION TO BLOOD DONATION, MICHIGAN BLOOD ADMINISTERS A VARIETY OF KEY PROGRAMS AND SPECIALTY SERVICES THAT FURTHER OUR LIFESAVING MISSION. THESE SERVICES INCLUDE A NATIONALLY RECOGNIZED CENTER FOR THE NATIONAL MARROW DONOR PROGRAM, ONE OF ONLY 25 PUBLIC CORD BLOOD BANKS IN AMERICA, AND WE WORK ALONGSIDE LOCAL HOSPITALS TO DELIVER A NUMBER OF MEDICAL SERVICES AND THERAPEUTIC PROCEDURES. MICHIGAN BLOOD IS ALSO AFFILIATED WITH VERSITI, AN ORGANIZATION WHOSE MEMBERS SHARE RESOURCES AND EXPERTISE TO IMPROVE PATIENT OUTCOMES, AS WELL AS CONDUCT LEADING EDGE MEDICAL RESEARCH AND PROVIDE NATIONWIDE DIAGNOSTIC LAB SERVICES. TO LEARN MORE ABOUT THE PROGRAM SERVICES MICHIGAN BLOOD PROVIDES PLEASE SEE DETAILED DESCRIPTIONS BELOW: BLOOD DONATION: VOLUNTEER BLOOD DONORS GIVE BLOOD AT EIGHT PERMANENT DONOR CENTERS THROUGHOUT MICHIGAN AND AT BLOOD DRIVES HOSTED BY COMMUNITY ORGANIZATIONS AND BUSINESSES. EACH MICHIGAN BLOOD REGION ALSO OPERATES A SELF-CONTAINED BLOOD CENTER ON WHEELS. THESE "BLOOD BUSES" HELP EXPAND OUR REACH TO SMALL COMMUNITIES AND URBAN AREAS WHERE SPACE IS AT A PREMIUM. SEE WWW.MIBLOOD.ORG FOR A COMPREHENSIVE LIST OF DONATION LOCATIONS. APHERESIS: SPECIAL EQUIPMENT MAKES IT POSSIBLE TO COLLECT ONE OR MORE SPECIFIC BLOOD COMPONENTS FROM A DONOR, WHILE RETURNING THE REMAINING COMPONENTS BACK TO THE DONOR. APHERESIS DONATIONS ALLOW A GREATER QUANTITY OF ONE COMPONENT TO BE DRAWN VERSUS A STANDARD WHOLE BLOOD DONATION. THESE LARGER COMPONENT-SPECIFIC DONATIONS HELP REDUCE THE NUMBER OF DONORS A PATIENT IS EXPOSED TO, WHICH IS PREFERRED BY MOST PHYSICIANS. ALSO, PATIENTS WITH DISEASES SUCH AS TTP, KIDNEY REJECTIONS, MYASTHENIA GRAVIS, SICKLE CELL DISEASE, OR LEUKEMIA CAN BE TREATED BY THE REMOVAL OF ONE OR MORE BLOOD COMPONENTS USING THERAPEUTIC APHERESIS TECHNOLOGY. MICHIGAN BLOOD STAFF AND EQUIPMENT TRAVEL TO GRAND RAPIDS AREA HOSPITALS TO PERFORM ROUGHLY 2,000 PROCEDURE'S ANNUALLY. MARROW/STEM CELL PROGRAM: IN THE PAST 20 YEARS, MICHIGAN BLOOD/VERSITI NMDP SERVICES HAS ESTABLISHED ONE OF THE PREMIER RECRUITMENT DONOR CENTER RECORDS IN THE UNITED STATES. MICHIGAN BLOOD/VERSITI ADDED MORE THAN 134,000 INDIVIDUALS WITH ADVANCED TISSUE TYPING TO THE REGISTRY OF POTENTIAL STEM CELL DONORS MAINTAINED BY THE BE THE MATCH REGISTRY (NATIONAL MARROW DONOR PROGRAM). IN 2010, THE DONOR CENTER RECEIVED THE DONOR MANAGEMENT RECOGNITION AWARD, A LIFETIME ACHIEVEMENT AWARD. NMDP SERVICES ALSO PROVIDES SUPPORT SERVICES FOR PATIENTS AND FAMILIES SEEKING COMPATIBLE STEM CELL DONORS. STEM CELL TRANSPLANTS REMAIN THE PRIMARY SOURCE OF HOPE FOR PATIENTS WITH CERTAIN KINDS OF LIFE-THREATENING DISEASES. MICHIGAN BLOOD HAS HELPED FACILITATE LIFESAVING STEM CELL TRANSPLANTS FOR OVER 700 PEOPLE AROUND THE WORLD. CORD BLOOD BANK/STEM CELL PROCESSING LABORATORY: MICHIGAN BLOOD CORD BLOOD BANK, THE FIRST OF ITS KIND IN MICHIGAN, HAS COLLECTED AND STORED BLOOD FROM MORE THAN 4,234 UMBILICAL CORDS. CORD BLOOD IS RICH IN STEM CELLS AND CORD BLOOD TRANSPLANTATION IS FINDING APPLICATION IN CHILDREN AND ADULTS AROUND THE GLOBE SUFFERING FROM CERTAIN LIFE-THREATENING DISEASES. LOCAL AVAILABILITY OF STEM CELL COLLECTION, PROCESSING, STORAGE, AND PRE-TRANSPLANT PREPARATION SUPPORTS THE LOCAL TRANSPLANT PROGRAM'S ABILITY TO OFFER ADVANCED MEDICAL CARE. IT ALSO OFFERS INCREASED CONVENIENCE AND REDUCED STRESS FOR PATIENTS AND FAMILIES WHO PREVIOUSLY HAD TO TRAVEL LONG DISTANCES FOR TRANSPLANT SERVICES. CELLULAR THERAPY: AS PART OF EVER-CHANGING MEDICAL LANDSCAPE, MICHIGAN BLOOD SUPPORTS PERSONALIZED CELLULAR THERAPY TREATMENTS USED IN A NUMBER OF CANCERS AND OTHER LIFE-THREATENING DISEASES. FOR INSTANCE, MICHIGAN BLOOD COLLECTS CELLS FROM PROSTATE CANCER PATIENTS TO BE USED IN THE PREPARATION OF PERSONALIZED TREATMENTS. OTHER APPLICATIONS ARE ROUTINELY BEING RESEARCHED AND TRIALED IN HOPES OF GAINING FDA APPROVAL. MICHIGAN BLOOD ALSO COLLECTS PATIENT WHITE CELLS AND PROCESSES THEM WITH UV LIGHT TO HELP TREAT GRAFT VS. HOST DISEASE AND CUTANEOUS T-CELL LYMPHOMA. DNA/HLA LABORATORY: THIS LABORATORY USES SPECIAL TECHNIQUES TO CONDUCT TISSUE TYPING AT THE GENETIC CODE LEVEL TO EVALUATE DONOR-PATIENT COMPATIBILITY BEFORE TRANSPLANTATION. LOCAL AVAILABILITY OF THESE SERVICES HELPS DOCTORS RESPOND FASTER TO URGENT PATIENT NEEDS CAUSED BY AGGRESSIVE DISEASES. PATIENTS WITH TRANSFUSION/PREGNANCY-RELATED SENSITIVITIES ALSO BENEFIT FROM THE SERVICES OF THE DNA/HLA LABORATORY WHICH HELPS PHYSICIANS DIAGNOSE, TREAT AND FIND APPROPRIATE BLOOD PRODUCTS. THE DNA/HLA LABORATORY ALSO TYPES APHERESIS DONORS TO IDENTIFY LIFE-SAVING MATCHES FOR PATIENTS NEEDING COMPONENT TRANSFUSION. REFERENCE LABORATORY: PATIENTS WITH COMPLEX TRANSFUSION-RELATED SENSITIVITIES BENEFIT FROM THE SERVICES OF THE RED CELL REFERENCE LABORATORY, WHICH PROVIDES INFORMATION THAT HELPS PHYSICIANS DIAGNOSE AND TREAT COMPLICATED CASES AND FIND RARE BLOOD TYPES FOR TRANSFUSION. THESE PATIENTS OFTEN ARE CRITICALLY ILL AND MAY SUFFER SERIOUS COMPLICATIONS (INCLUDING DEATH) WITHOUT SPECIAL LABORATORY SERVICES TO HELP THEIR DOCTORS ASSESS THE RISKS OF TRANSFUSION REACTIONS AND DONOR/RECIPIENT INCOMPATIBILITIES. VOLUNTEERISM: MICHIGAN BLOOD OFFERS A WIDE VARIETY OF OPPORTUNITIES FOR COMMUNITY MEMBERS INTERESTED IN VOLUNTEERING THEIR TIME TO HELP THEIR COMMUNITY AND SUPPORT MICHIGAN BLOOD'S LIFESAVING MISSION. 47149196 true true false false false false false false false true true true false false false true false true false false false false false false true false false false false true false false false false false false false false true false false false false true false false false true 20 0 true 522 true false false false false false true true false false false false X 15 14 false false true false true true true true true false false true true true true true true true true false MI X JODI YENCHAR 6162338627 1036 FULLER NE GRAND RAPIDS MI 49503 X Chris Miskel CEO-as of 2/17 7.0 48.0 X X 77001 539005 33085 James Wilson President; Board-thru 8/17 55.0 0.0 X X 301815 0 35846 Paul D Smith Jr Secretary/Treasurer-thru 8/17 1.0 0.0 X X 0 0 0 James M Rauh Treasurer-as of 8/17 1.0 4.0 X X 0 0 0 Mitchell G Watt Chair-thru 8/17;Sec-as of 8/17 1.0 3.0 X X 0 0 0 John J Perras VC-thru 8/17;Board-as of 8/17 1.0 3.0 X X 0 0 0 Richard J Fotsch Board-thru 8/17;Chr-as of 8/17 1.0 4.0 X X 0 0 0 L Alan Whaley Board-thru 8/17;VC-as of 8/17 1.0 4.0 X X 0 0 0 Cathy Buck Board Member-as of 8/17 1.0 3.0 X 0 0 0 Fred Geilfuss Board Member-as of 8/17 1.0 3.0 X 0 0 0 Thomas Hauske Jr Board Member-as of 8/17 1.0 3.0 X 0 0 0 Dale Kent Board Member-as of 8/17 1.0 3.0 X 0 0 0 Gregory Larkin Board Member-as of 8/17 1.0 4.0 X 0 0 0 Robert H Manegold Board Member-as of 8/17 1.0 4.0 X 0 0 0 Jeffrey S McDonald Board Member-as of 8/17 1.0 3.0 X 0 0 0 John O'Donnell MD Board Member-thru 8/17 1.0 0.0 X 0 0 0 E Randall Wright Board Member-as of 8/17 1.0 4.0 X 0 0 0 Peter Ziegler Board Member-as of 8/17 1.0 4.0 X 0 0 0 Leeann Wietekamp Senior Medical Director 55.0 0.0 X 306664 0 22252 Sandi Lemons VP & Chief HR - thru 6/17 10.0 45.0 X 74697 324751 22275 Maureen Kwiecinski EVP & General Counsel 8.0 47.0 X 69648 394670 21635 Anthony Watkins EVP & Chief Financial Officer 5.0 50.0 X 51472 463250 38681 Margaret McElligott VP & Chief Quality Officer 7.0 48.0 X 35694 261746 33768 Lynne Briggs VP & Chief Information Officer 6.0 49.0 X 34639 311751 39820 James Weidner VP & Chief HR - as of 9/17 11.0 44.0 X 22839 91355 3147 Gitesh Dubal vP & CHIEF MARKETING OFFICER 0.0 55.0 X 0 126840 3147 M Elizabeth Atkinson Cole Associate Medical Director 55.0 0.0 X 137413 0 10954 Cindy Raven Histocompatability Director 55.0 0.0 X 117729 0 18135 Robert Eluskie Director of Info Technology 55.0 0.0 X 116546 0 30807 Mary C Lawson Director of Donor Recruitment 55.0 0.0 X 110613 0 4611 Dawn M Kaiser Director of Donor Services 55.0 0.0 X 106793 0 22038 Bill J Rietscha Former President/CEO 0.0 0.0 X 291943 0 57233 1855506 2513368 397434 11 true true false 0 11380 177900 213426 177512 402706 BLOOD PRODUCTS/TESTING 621500 48749602 48749602 SPECIAL SERVICES 621500 6719676 6719676 55469278 385525 385525 0 0 0 0 0 25831461 2875 25502714 6312 328747 -3437 325310 325310 8285 11380 15350 -7065 -7065 6410 8337 -1927 -1927 0 0 0 CREDIT CARD REBATES 900099 2903 2903 COURIER SERVICES 900099 2320 2320 CLASS ACTION PROCEEDS 900099 765 765 122 122 6110 56579937 55469278 707953 0 0 0 0 1056643 1056643 0 16720046 14225818 2494228 470773 419466 51307 2781515 2350403 431112 1235208 1026061 209147 0 0 77405 77405 0 0 14146 14146 6800361 6958092 -157731 0 252994 913 252081 545681 385571 160110 255428 255428 0 2584370 1016319 1568051 952658 918930 33728 0 327821 249220 78601 42699 42699 0 1619494 665703 953791 243288 243288 IMPORTED BLOOD COMPONENETS 12670971 12670971 MEDICAL LAB SUPPLIES 5811864 5848572 -36708 DONOR RECRUITMENT 486256 313585 172671 DUES & MEMBERSHIPS 63319 5529 57790 126605 94043 32562 55139545 47149196 7990349 0 3131486 5546615 0 0 271302 93329 5851195 4867653 0 0 0 0 0 0 1398929 1082216 669888 553864 31809301 20007405 12200871 11801896 0 0 11539525 13085753 0 0 0 0 340957 327587 35404153 37358913 5035908 5504314 0 0 0 0 0 0 0 0 0 0 1636346 1029851 0 0 0 0 6672254 6534165 X 28601911 30661899 119838 152699 10150 10150 28731899 30824748 35404153 37358913 1440392 652457 X false true X true false X 98507 2206994 413021 490987 402706 3612215 21965633 41106448 46720288 55986833 55469278 221248480 0 0 0 22064140 43313442 47133309 56477820 55871984 224860695 0 11144406 20402773 20475467 27650583 27648190 107321419 11144406 20402773 20475467 27650583 27648190 107321419 117539276 268012 452545 400847 232168 385525 1739097 0 268012 452545 400847 232168 385525 1739097 0 10882 18881 13936 17684 20805 82188 22343034 43784868 47548092 56727672 56278314 226681980 0.51852 0.50952 0.00767 0.00792 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 10150 10150 10150 10150 10150 10150 10150 10150 10150 10150 1.00000 false true true 2546071 2546071 14878680 9021695 5856985 1032653 590677 441976 10723793 8234125 2489668 2628104 2160908 467196 11801896 MUTUAL FUNDS 13085753 F 13085753 0 0 X 57245372 652457 652457 56592915 14146 -27124 -12978 56579937 55152523 27124 27124 55125399 14146 14146 55139545 Part V Endowments The intended use of the organization's endowment funds is to perpetuate the mission of Michigan Blood. Additionally, the filing organization is a beneficiary of the BloodCenter Research Foundation's ("BCRF") endowment as a supported organization. The BCRF Board designated endowment funds are designated by the board as endowment funds to ensure the continuing availability of funds for research purposes. The amount of the BCRF total endowment as of 12/31/2017 was $86,045,725 and was all board restricted. Part X Income Taxes Versiti, BloodCenter, Heartland, Michigan, Indiana and the Foundation have all received tax determination letters confirming that the organizations qualify as tax-exempt organizations under section 501(c)(3) of the Internal Revenue Code (IRC). The Organization follows guidance that clarifies the accounting for uncertainty in tax positions taken or expected to be taken in a tax return, including issues relating to financial statement recognition and measurement. This guidance provides that the tax effects from an uncertain tax position can only be recognized in the financial statements if the position is more likely than not to be sustained if the position were to be challenged by a taxing authority. The assessment of the tax position is based solely on the technical merits of the position, without regard to the likelihood that the tax position may be challenged. Versiti, BloodCenter, Heartland, Michigan, Indiana and the Foundation are exempt from federal income tax under IRC section 501(c)(3), though they are subject to tax on income unrelated to their exempt purposes, unless that income is otherwise excluded by the IRC. The Organization has processes presently in place to ensure the maintenance of its tax-exempt status; to identify and report unrelated income; to determine its filing and tax obligations in jurisdictions for which it has nexus; and to identify and evaluate other matters that may be considered tax positions. BloodCenter and the Foundation have filed federal and state of Wisconsin income tax returns to report unrelated business income through 2009 and are no longer subject to tax authority examinations for years prior to 2010 under the federal and state statute. Management has determined that there is no unrelated business income to report for BloodCenter or the Foundation for 2010 through 2017, and income tax returns are not required to be filed. Therefore, as the statute of limitations will remain open for returns not filed, tax years 2010 through 2017, will remain open to audit for both federal and state purposes. Michigan has not historically filed any unrelated business income tax returns; therefore, tax years remain open for years in which an income tax return has not been filed. In years prior to 2014, heartland filed both federal and state of Illinois income tax returns to report a zero amount of unrelated business income. Management has determined that there is no unrelated business income to report for Heartland for tax years 2014 through 2017, and income tax returns are not required to be filed; therefore, as the statute of limitations will remain open for returns not filed, tax years 2014 through 2017, will remain open to audit for both federal and state purposes. In years prior to 2014, Indiana filed federal unrelated business income tax returns to report a zero amount of unrelated business income. In 2014 through 2016, Indiana filed federal and Indiana returns to report an unrelated business loss. The statute of limitations will remain open for both federal and state purposes for any returns not filed. Versiti has not filed any unrelated business income tax returns; therefore the years since 2012, the year of inception, are still open to examination. The Organization has determined that there are no material uncertain tax positions that require recognition or disclosure in the consolidated financial statements. The Organization recognizes, if necessary, interest and penalties related to unrecognized tax benefits in the provision for income taxes. There were no interest or penalties related to income taxes that have been accrued or recognized as of and for the years ended December 31, 2017 and 2016. On December 22, 2017, tax reform legislation commonly known as the Tax Cuts and Jobs Act of 2017 (the Act) was passed; resulting in significant modifications to existing tax law. There were no material effects on the Organization's financial statements as a result of the Act. Management is evaluating the ongoing impact of the Act on the Organization. Part XI, Line 4B Other Changes to Revenue Loss on Sale of Fixed Assets Reported with Revenue $ (3,437) Fundraising Expenses Reported with Revenue (15,350) Gaming Expenses Reported wth Revenue (8,337) ------- TOTAL $(27,124) Part XII, Line 2D Other Changes to Expenses Loss On Sale of Fixed Assets Reported with Revenue $ 3,437 Fundraising Expenses Reported with Revenue 15,350 Gaming Expenses Reported with Revenue 8,337 ------- Total $27,124 GOLF OUTING 19665 11380 8285 89 5750 5188 4323 0 19665 11380 8285 89 5750 5188 4323 15350 -7065 MI X X X X true false false false false false false true false Chris Miskel CEO-as of 2/17 60328 422294 14375 100625 2298 16086 2420 16941 1715 12009 81136 567955 0 0 James Wilson President; Board-thru 8/17 259540 0 32352 0 9923 0 10800 0 25046 0 337661 0 0 0 Leeann Wietekamp Senior Medical Director 289940 0 0 0 16724 0 10800 0 11452 0 328916 0 0 0 Sandi Lemons VP & Chief HR - thru 6/17 30929 134466 14120 61390 29648 128895 822 3574 3343 14536 78862 342861 0 0 Maureen Kwiecinski EVP & General Counsel 50512 286232 16251 92086 2885 16352 2835 16065 410 2325 72893 413060 0 0 Anthony Watkins EVP & Chief Financial Officer 37161 334447 14108 126972 203 1831 1978 17804 1890 17009 55340 498063 0 0 Margaret McElligott VP & Chief Quality Officer 24818 181995 8316 60980 2560 18771 2446 17940 1606 11776 39746 291462 0 0 Lynne Briggs VP & Chief Information Officer 25969 233726 8410 75689 260 2336 2093 18842 1888 16997 38620 347590 0 0 Bill J Rietscha Former President/CEO 4102 0 237437 0 50404 0 49483 0 7750 0 349176 0 50404 0 Part I, Line 4A Severance Payments An individual left the organization in 2017. The individual received severance in 2017, which is included on Schedule J, Part II, Column B(III). Due to confidentiality agreements, neither the name nor the amount will be listed. Part I, Line 7 Non-Fixed Payments Incentive payout opportunities, based on percentage of base pay rate, are available to certain employees of the filing organization. While levels of the incentive payout opportunity are fixed and determined percentages of base compensation, the incentive payout is subject to the review of accomplishments/objectives and the ultimate determination of incentive compensation is subject to president/CEO and executive committee of the board approval. X GIFT CARDS 1 60000 FMV X RAFFLE ITEMS 44 8012 FMV X FAIR VOUCHERS 1 67500 FMV X TURKEY VOUCHERS 1 42000 FMV false false false Part VI, Section A, Line 4 Significant changes to governing documents The filing organization's bylaws were amended on August 16, 2017 for the following changes: -The number and composition of the Board of Directors. The board of directors shall consist of not less than three (3), nor more than twenty-five (25) directors, and shall be comprised of the then-serving directors of the corporate member. -Each director shall serve for the same term such individual serves as a Director of the Corporate member. -Committees: The board of directors, by resolution dated September 19, 2012, delegated oversight of the corporation's audit and compliance functions to the Versiti Audit & Finance Committee. The board of directors, by resolutions dated September 21, 2016, delegated oversight of the governance function to the Versiti Governance Committee. Part VI, Section A, Line 6 Members or Stockholders VERSITI, INC. (A 501(C)(3) ORGANIZATION) IS THE SOLE VOTING MEMBER. Part VI, Section A, Lines 7a and 7b Member or Stockholder Powers VERSITI, INC. HAS RESERVE POWERS, INCLUDING THE ABILITY TO ELECT A MAJORITY OF DIRECTORS. Part VI, Section B, Line 11b Form 990 Review MICHIGAN BLOOD UTILIZES GRANT THORNTON LLP TO COMPLETE THE IRS FORM 990 AND RELATED SCHEDULES. FOLLOWING COMPLETION, THEY ARE REVIEWED BY THE FINANCE/AUDIT COMMITTEE. THE FULL BOARD IS PROVIDED A COPY OF THE FORM 990 PRIOR TO FILING. Part VI, Section B, Line 12c Conflict of Interest Policy ANNUALLY CONFLICT OF INTEREST STATEMENTS ARE COMPLETED BY ALL BOARD OF DIRECTORS AND KEY MEMBERS OF THE MANAGEMENT TEAM. RESPONSEs ARE COMPILED BY VERSITI'S LEGAL SERVICES TEAM TO DETERMINE IF ANY CONFLICTS EXIST. IDENTIFIED CONFLICTS ARE ADDRESSED IN ACCORDANCE WITH THE POLICy. Part VI, Section B, Lines 15a and 15B Compensation Process THE COMPENSATION COMMITTEE OF THE VERSITI BOARD OF DIRECTORS, ACTING IN ITS CAPACITY AS THE COMPENSATION COMMITTEE, SETS AND MONITORS THE COMPENSATION PHILOSOPHY FOR VERSITI AND THE RELATED ENTITIES THAT IT SUPPORTS, INCLUDING MICHIGAN BLOOD. OTHER THAN THE VERSITI PRESIDENT & CHIEF EXECUTIVE OFFICER, THE COMPENSATION COMMITTEE DOES NOT INCLUDE MEMBERS OF MANAGEMENT AND IS COMPRISED ENTIRELY OF INDIVIDUALS WHO DO NOT HAVE A CONFLICT OF INTEREST WITH RESPECT TO VERSITI OR MICHIGAN BLOOD COMPENSATION ARRANGEMENTS. THE VERSITI PRESIDENT AND CHIEF EXECUTIVE OFFICER RECUSES HER/HIMSELF FROM ALL DISCUSSIONS AND APPROVALS RELATED TO HER/HIS COMPENSATION. THE VERSITI COMPENSATION COMMITTEE REVIEWS MICHIGAN BLOOD EXECUTIVE COMPENSATION ARRANGEMENTS TO ENSURE SUCH ARRANGEMENTS ARE FAIR, REASONABLE, AND NOT EXCESSIVE WHEN COMPARED TO SIMILARLY-SITUATED EXECUTIVES. EXECUTIVE COMPENSATION ARRANGEMENTS ARE REVIEWED FOR REASONABLENESS AND APPROVED BY THE COMPENSATION COMMITTEE ANNUALLY IN ACCORDANCE WITH THE VERSITI REASONABLENESS REVIEW POLICY. THE COMPENSATION COMMITTEE ASSESSES THE REASONABLENESS OF EXECUTIVE COMPENSATION ARRANGEMENTS AFTER IT OBTAINS AND REVIEWS APPROPRIATE DATA FOR COMPARABILITY FROM THE HUMAN RESOURCE DEPARTMENT AND AN INDEPENDENT COMPENSATION CONSULTANT. THE COMPENSATION COMMITTEE ENGAGES A QUALIFIED INDEPENDENT COMPENSATION CONSULTANT ANNUALLY. THE INDEPENDENT CONSULTANT PERFORMS AN ANALYSIS OF COMPENSATION LEVELS AT REGIONAL AND NATIONAL ORGANIZATIONS OF COMPARABLE SIZE, SCOPE AND STRUCTURE AND PROVIDES THE COMMITTEE WITH COMPREHENSIVE DATA ON THE AVAILABILITY OF SIMILAR SERVICES WITHIN THE GEOGRAPHIC AREA, COMPENSATION SURVEYS, WRITTEN OFFERS FROM SIMILAR INSTITUTIONS, AND OTHER INFORMATION RELEVANT TO COMPARABILITY OF COMPENSATION. THE COMPENSATION COMMITTEE'S REVIEW, RECOMMENDATIONS AND APPROVALS ARE DOCUMENTED CONCURRENTLY IN THE COMMITTEE MINUTES, WHICH ARE SUBSEQUENTLY REVIEWED AND APPROVED BY THE COMPENSATION COMMITTEE AS REASONABLE, ACCURATE AND COMPLETE. VERSITI AND MICHIGAN BLOOD HAVE INCENTIVE PROGRAMS FOR THE CHIEF EXECUTIVE OFFICER AND OTHER CORPORATE OFFICERS DESCRIBED IN DETAILED WRITTEN POLICIES APPROVED BY THE COMPENSATION COMMITTEE ANNUALLY. EVALUATION AND COMPENSATION REVIEW -CEO - EACH YEAR, THE EXECUTIVE/COMPENSATION COMMITTEE EVALUATES THE VERSITI/MICHIGAN BLOOD CEO'S PERFORMANCE AGAINST ESTABLISHED OBJECTIVES, DETERMINES INCENTIVE PAYMENT AND MERIT INCREASE BASED UPON PERFORMANCE AND MARKET DATA PROVIDED BY THE THIRD PARTY COMPENSATION CONSULTANT, AND WORKS WITH THE CEO TO ESTABLISH OBJECTIVES FOR THE NEXT YEAR. -OTHER CORPORATE OFFICERS - EACH YEAR, THE VERSITI/MICHIGAN BLOOD CEO REVIEWS THE PERFORMANCE AND THE ACHIEVEMENT OF INDIVIDUAL GOALS AND OBJECTIVES OF EACH VERSITI/MICHIGAN BLOOD CORPORATE OFFICER. THE VERSITI/MICHIGAN BLOOD CEO PRESENTS HIS/HER RECOMMENDATIONS TO THE COMPENSATION COMMITTEE, WHICH REVIEWS AND APPROVES RECOMMENDED COMPENSATION RANGES, AND APPROVES FINAL SALARY AND INCENTIVE PAYMENTS. CORPORATE OFFICERS ARE POSITIONED WITHIN THE APPROPRIATE SALARY RANGE BASED UPON: -EXECUTIVE'S KNOWLEDGE, COMPETENCIES, AND EXPERIENCE, -PERFORMANCE OF THE EXECUTIVE'S AREAS OF RESPONSIBILITY, -THE EXECUTIVE'S CONTRIBUTION TO OVERALL PERFORMANCE, -THE IMPORTANCE OF RETAINING THE EXECUTIVE, -INTERNAL EQUITY CONSIDERATIONS, -THE FINANCIAL RESOURCES AVAILABLE, AND -EXECUTIVE BASE SALARY INCREASES PROVIDED IN THE COMPETITIVE MARKET Part VI, Section C, Line 19 Organization's Documents Open to the Public MICHIGAN BLOOD MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST. Part VII Average Hours The hours listed on form 990, part vii are representative of an average for the officers and executive team. each individual person's weekly tally may be greater or lesser per week based on their individual roles and responsibilities within the filing organization and related parties. FORM 990 PART IX LINE 11G DESCRIPTION:OUTSIDE LAB SERVICES TOTAL FEES:5781328 FORM 990 PART IX LINE 11G DESCRIPTION:SHIPPING/POSTAGE TOTAL FEES:383043 FORM 990 PART IX LINE 11G DESCRIPTION:CONSULTANT TOTAL FEES:309020 FORM 990 PART IX LINE 11G DESCRIPTION:PURCHASED SERVICES TOTAL FEES:179040 FORM 990 PART IX LINE 11G DESCRIPTION:PRINTING TOTAL FEES:115894 FORM 990 PART IX LINE 11G DESCRIPTION:LAUNDRY TOTAL FEES:22249 FORM 990 PART IX LINE 11G DESCRIPTION:RECORDS TOTAL FEES:9787 FORM 990 PART IX LINE 11G DESCRIPTION:IN HOUSE SERVICES TOTAL FEES: BLOODCENTER OF WISCONSIN INC 638 NORTH 18TH STREET MILWAUKEE WI 532332121 390807235 BLOOD WI 501(C)(3) 07 VERSITI false BLOODCENTER RESEARCH FOUNDATION INC PO BOX 2178 638 NORTH 18TH MILWAUKEE WI 53201 391372542 SUPPORTING WI 501(C)(3) 12B VERSITI false VERSITI INC PO BOX 2178 638 NORTH 18TH MILWAUKEE WI 53201 454675354 SUPPORTING WI 501(C)(3) 12B NA false AURORA AREA BLOOD BANK DBA HEARTLAND 1200 N HIGHLAND AVENUE AURORA IL 60506 362179768 BLOOD IL 501(C)(3) 10 VERSITI false CENTRAL INDIANA REGIONAL BLOOD CENTER 3450 NORTH MERIDIAN STREET INDIANAPOLIS IN 46208 350991629 BLOOD IN 501(C)(3) 10 VERSITI false false false false false false false false true false false false true true false true true true false false